menu
    • menu

    Company profile for Aditxt

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. Our immune reprogramming technology called Apoptotic DNA Immunotherapy™ (ADi™) is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. Our immune monitor...
    We are a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. Our immune reprogramming technology called Apoptotic DNA Immunotherapy™ (ADi™) is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. Our immune monitoring technology called Aditxtscore™ is designed to provide a personalized comprehensive profile of the immune system

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AditxtUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Richmond, VA 23219
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aditxt.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aditxt/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aditxt Reveals Growth Plans for Bitxbio and Pearsanta IPO
    Aditxt Reveals Growth Plans for Bitxbio and Pearsanta IPO

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118746973/en/Aditxt-Provides-Updates-on-its-Growth-Vision-for-bitXbio-Planned-Digital-Asset-Treasury-Pearsantas-Planned-IPO-And-Evofems-Plan-to-Regain-a-National-Listing

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Aditxt To Implement 1-For-113 Reverse Stock Split On November 3
    Aditxt To Implement 1-For-113 Reverse Stock Split On November 3

    29 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251029193797/en/Aditxt-Inc.-NASDAQ-ADTX-Announces-1-for-113-Reverse-Stock-Split-Effective-at-the-Open-of-Trading-on-November-3-2025

    BUSINESSWIRE
    29 Oct 2025
    Share Share
    Pearsanta Begins First Human Trial for Endometriosis Diagnostic
    Pearsanta Begins First Human Trial for Endometriosis Diagnostic

    27 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251027553743/en/Aditxt-Subsidiary-Pearsanta-Begins-Enrollment-in-First-Human-Study-of-Blood-Based-Diagnostic-for-Endometriosis-a-Condition-Affecting-190-Million-Women-Worldwide-and-Representing-a-%241.45-Billion-Global-Market

    BUSINESS WIRE
    27 Oct 2025
    Share Share
    Adimune Highlights DNA Immune Reprogramming, 96 Patents
    Adimune Highlights DNA Immune Reprogramming, 96 Patents

    25 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825106664/en/Aditxts-Subsidiary-Adimune-Highlights-Its-Approach-to-Reprogramming-the-Immune-System-Through-DNA-Instructions-Now-with-96-Granted-and-22-Pending-Patents-Targeting-Autoimmunity-Market-Estimated-at-Over-%24160-Billion-by-2030

    BUSINESSWIRE
    25 Aug 2025
    Share Share
    Aditxt, Crypto.com Ink Deal for Custodial Crypto Account
    Aditxt, Crypto.com Ink Deal for Custodial Crypto Account

    11 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250811483794/en/Aditxt-and-Crypto.com-Sign-Agreement-for-Custodial-Crypto-Account-Announce-ADTX-Share-Access-on-Crypto.com-as-Part-of-the-Larger-bitXbio-Initiative

    BUSINESSWIRE
    11 Aug 2025
    Share Share
    Aditxt's Pearsanta Taps Spartan Capital To Boost Mitomic Platform
    Aditxt's Pearsanta Taps Spartan Capital To Boost Mitomic Platform

    29 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250729477223/en/Aditxts-Subsidiary-Pearsanta-Inc.-Engages-Spartan-Capital-as-Lead-Underwriter-for-its-Planned-IPO-Intending-to-Drive-Clinical-Validation-and-Commercial-Rollout-of-Its-Mitomic-Platform-Technology-for-Early-Detection-of-Cancers-and-Other-Diseases

    BUSINESSWIRE
    29 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search